Immuron CEO, Steven Lydeamore Investor Webinar Presentation
November 28 2023 - 6:33AM
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and
globally integrated biopharmaceutical company is pleased to invite
shareholders to attend an investor webinar “Coffee Microcaps
Morning Meeting”, to be held on Thursday, 30th of November,
2023, 9:00am ADEST.
CEO Steven Lydeamore
will provide an overview and update on the business and upcoming
milestones.
Following the
presentation, attendees will have the opportunity to ask questions
directly to Mr Lydeamore during a moderated Q & A session.
This webinar can be
viewed live via zoom & you register via the link below.
Zoom:
https://us02web.zoom.us/webinar/register/WN_73dRq8CsQK6Ahor0F8UzgA#/registration
Authorised for release
by the Board of Immuron Limited.
COMPANY
CONTACT:Steven
LydeamoreChief Executive OfficerPh: +61 (0)3 9824
5254info@immuron.com |
|
About Immuron
Immuron Limited (ASX: IMC, NASDAQ: IMRN) is an
Australian biopharmaceutical company focused on developing and
commercialising orally delivered targeted polyclonal antibodies for
the treatment of infectious diseases.
For more information visit:
http://www.immuron.com
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Jul 2023 to Jul 2024